Solara Active Pharma Sciences Limited has informed the exchange about intimation in connection with the receipt of Rectification Order

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in Date: August 28, 2026 The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra-Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1 Dear Sir / Madam, Subject: Intimation in connection with the receipt of Rectification Order This is with reference to the intimation filed by the Company on March 18, 2026, disclosing the details of a Demand notice received from Deputy Commissioner of Income Tax, Income Tax Department. The Company had filed an application for rectification of the Demand under Section 154 of the Income Tax Act, 1961, on the grounds that the tax demand had been computed incorrectly by the Income Tax Department and required correction. Pursuant to the said application, the Company has received a Rectification Order under Section 154 read with Section 147 of the Income Tax Act, 1961, from the Assistant Commissioner of Income Tax, Central Circle 3, Thane. The order rectifies the error in the tax computation and consequently drops the Tax demand. The details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure A. The above information will also be available on the website of the Company i.e. https://solara.co.in/ This is for your information and records. Thanking You, Yours Faithfully, For Solara Active Pharma Sciences Limited Pooja Jaya Kumar Company Secretary and Compliance Officer ICSI Membership No: A57415 Encl. as above Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: Cyber One, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033 Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in Annexure A Details as required under SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Sr. No Particulars Details 1. Name of the listed company Solara Active Pharma Sciences Limited 2. Type of communication received The Company has received a Rectification Order under Section 154 read with Section 147 of the Income-tax Act, 1961. 3. Date of receipt of communication Company received the Rectification Order on August 08, 2026 4. Authority from whom communication Assistant Commissioner of Income Tax, Central received Circle-3, Thane 5. Brief summary of the material contents of The Company had filed an application for rectification the communication received, including under Section 154 of the Income-tax Act, 1961, as the reasons for receipt of the communication tax demand of Rs. 161.92 Crores raised pursuant to the Demand Notice received on March 17, 2026, was incorrectly computed. Upon examination of the rectification application, the Assistant Commissioner of Income Tax, Central Circle 3, Thane, passed a Rectification Order under Section 154 read with Section 147 of the Income-tax Act, 1961, rectifying the error and reducing the tax demand to Nil. 6. Period for which communication would be Assessment Year 2019-20 applicable, if stated 7. Expected financial implications on the On passing of Rectification Order, there is no pending listed company, if any demand on the Company against the Demand Notice received on March 17, 2026. There is no impact on Financials /operation or other activities of the Company in this regard as the demand has been dropped. 8. Details of any aberrations/non-compliances The rectification order does not identify any identified by the authority in the aberration, non-compliance, violation, or default on communication the part of the Company. 9. Details of any penalty or restriction or Nil sanction imposed pursuant to the communication 10. Action(s) taken by listed company with No further action is required to be taken by the respect to the communication Company in relation to the said demand. Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: Cyber One, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033